NCT00171535已完成3 期
A Study to Evaluate the Safety and Efficacy of Valsartan/Amlodipine Compared to Lisinopril/Hydrochlorothiazide Given Once Daily for 6 Weeks is Patients With Severe Hypertension
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- Novartis
- 入组人数
- 130
- 试验地点
- 2
- 主要终点
- Adverse events and serious adverse events at each study visit for 6 weeks
研究概览
简要总结
This study will assess the effectiveness and safety of different combination antihypertensive treatments in patients with severe hypertension
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with severe hypertension
排除标准
- •History of stroke, myocardial infarction, heart failure, chest pain, abnormal heart rhythm
- •Liver, kidney, or pancreas disease
- •Insulin dependent diabetes
- •Allergy to certain medications used to treat high blood pressure
- •Other protocol-defined inclusion/exclusion criteria may apply.
结局指标
主要结局
Adverse events and serious adverse events at each study visit for 6 weeks
次要结局
- Sitting and standing blood pressure measurements after 6 weeks
- Laboratory test data after 6 weeks
- Vital signs at each study visit for 6 weeks
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
Candesartan Cilexetil + Chlorthalidone + Amlodipine Versus Exforge HCT®️ for Systemic Arterial HypertensionHypertensionNCT05920005Hospital Israelita Albert Einstein702
已完成
4 期
Valsartan/Amlodipine As Compared to Losartan Treatment in Stage 2 Systolic HypertensionStage 2 Systolic HypertensionNCT00931710Novartis488
已完成
3 期
Efficacy and Safety of Aliskiren and Atenolol in Adults (>18) With Mild to Moderate HypertensionHypertensionNCT00262236Novartis693
已完成
不适用
Evaluation of the Antihypertensive effectIveness, Tolerability, and Adherence With Amlodipine/ Indapamide/ Perindopril Triple Single-pill Combination in Hypertensive Patients Without Concomitant Antihypertensive Therapy (TRIPTYCH)Arterial HypertensionHTNNCT06259175Servier Russia396
已完成
3 期
A Clinical Study to Evaluate the Safety and Efficacy of the Combination of Aliskiren and Valsartan in Hypertensive Non Responders PatientsHypertensionNCT00219193Novartis641